Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mathieu F Chevalier

12PUBLICATIONS

72CO-AUTHORS

Innate immunityHost-parasite interactionsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Nov 24, 2025

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Mar 05, 2025

Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Mathieu F Chevalier, Vincent Allain, Julien Gras

|Dec 15, 2023

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

Laurent Derré, Ilaria Lucca, Valérie Cesson

|Aug 24, 2022

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.

Sylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug

|Jul 12, 2022

Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse.

Viviane Gournay, Nicolas Vallet, Vivien Peux

|Jun 21, 2022

Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.

Alexis Cuffel, Vincent Allain, Lionel Faivre

Pageof 2

Frequent Collaborators

6 joint publications

Sophie Caillat-Zucman

5 joint publications

Laurent Derré

3 joint publications

Juliette Villemonteix

2 joint publications

Agathe Carrier

2 joint publications

Sonia Domingos-Pereira

2 joint publications

Julien Racle

2 joint publications

Jean-Eudes Fahrner

2 joint publications

Eric de Sousa

2 joint publications

Lisa Derosa

2 joint publications

Markus Maeurer

Frequent Collaborators

6 joint publications

Sophie Caillat-Zucman

5 joint publications

Laurent Derré

3 joint publications

Juliette Villemonteix

2 joint publications

Agathe Carrier

Top Related Videos

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on : Aug 30, 2019

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on : Jul 13, 2019

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on : Aug 30, 2019

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on : Jul 13, 2019

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos